Asthma outcomes workshop: overview.

William W. Busse, Wayne J Morgan, Virginia Taggart, Alkis Togias

Research output: Contribution to journalArticle

79 Citations (Scopus)

Abstract

Asthma clinical research will highly benefit from standardization of major outcomes in terms of definition and assessment methodology. This will permit useful comparisons across interventional or observational studies and will allow more effective data sharing. National Institutes of Health (NIH) institutes and the Agency for Healthcare Research and Quality convened a workshop involving 7 expert subcommittees to propose which asthma outcomes should be assessed with standardized methodology in future asthma clinical research studies. Each subcommittee utilized comprehensive literature reviews and expert opinion to compile a list of asthma outcomes and classified them as either core (required in future studies), supplemental (to be used according to study aims and standardized), or emerging (requiring validation and standardization). This work was discussed at an NIH-organized workshop in March 2010 and finalized in September 2011. Outcomes for study participant characterization, as well as for prospective clinical trial intervention and observational studies, were proposed for adults and children, and methodologies for outcome collection and reporting were determined. Furthermore, the workshop identified areas in which new outcomes or instruments for their measurement need to be developed and validated. Standardized outcomes for clinical research in asthma have been proposed. Participating NIH institutes and other federal agencies will consider these recommendations in future clinical research initiatives in asthma. Published by Mosby, Inc.

Original languageEnglish (US)
JournalJournal of Allergy and Clinical Immunology
Volume129
Issue number3 Suppl
StatePublished - Mar 2012

Fingerprint

Asthma
Education
National Institutes of Health (U.S.)
Observational Studies
Research
Outcome Assessment (Health Care)
Information Dissemination
Health Services Research
Expert Testimony
Clinical Trials

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Busse, W. W., Morgan, W. J., Taggart, V., & Togias, A. (2012). Asthma outcomes workshop: overview. Journal of Allergy and Clinical Immunology, 129(3 Suppl).

Asthma outcomes workshop : overview. / Busse, William W.; Morgan, Wayne J; Taggart, Virginia; Togias, Alkis.

In: Journal of Allergy and Clinical Immunology, Vol. 129, No. 3 Suppl, 03.2012.

Research output: Contribution to journalArticle

Busse, WW, Morgan, WJ, Taggart, V & Togias, A 2012, 'Asthma outcomes workshop: overview.', Journal of Allergy and Clinical Immunology, vol. 129, no. 3 Suppl.
Busse, William W. ; Morgan, Wayne J ; Taggart, Virginia ; Togias, Alkis. / Asthma outcomes workshop : overview. In: Journal of Allergy and Clinical Immunology. 2012 ; Vol. 129, No. 3 Suppl.
@article{bb5ec78dc0b84b48871b8d551bf4b49a,
title = "Asthma outcomes workshop: overview.",
abstract = "Asthma clinical research will highly benefit from standardization of major outcomes in terms of definition and assessment methodology. This will permit useful comparisons across interventional or observational studies and will allow more effective data sharing. National Institutes of Health (NIH) institutes and the Agency for Healthcare Research and Quality convened a workshop involving 7 expert subcommittees to propose which asthma outcomes should be assessed with standardized methodology in future asthma clinical research studies. Each subcommittee utilized comprehensive literature reviews and expert opinion to compile a list of asthma outcomes and classified them as either core (required in future studies), supplemental (to be used according to study aims and standardized), or emerging (requiring validation and standardization). This work was discussed at an NIH-organized workshop in March 2010 and finalized in September 2011. Outcomes for study participant characterization, as well as for prospective clinical trial intervention and observational studies, were proposed for adults and children, and methodologies for outcome collection and reporting were determined. Furthermore, the workshop identified areas in which new outcomes or instruments for their measurement need to be developed and validated. Standardized outcomes for clinical research in asthma have been proposed. Participating NIH institutes and other federal agencies will consider these recommendations in future clinical research initiatives in asthma. Published by Mosby, Inc.",
author = "Busse, {William W.} and Morgan, {Wayne J} and Virginia Taggart and Alkis Togias",
year = "2012",
month = "3",
language = "English (US)",
volume = "129",
journal = "Journal of Allergy and Clinical Immunology",
issn = "0091-6749",
publisher = "Mosby Inc.",
number = "3 Suppl",

}

TY - JOUR

T1 - Asthma outcomes workshop

T2 - overview.

AU - Busse, William W.

AU - Morgan, Wayne J

AU - Taggart, Virginia

AU - Togias, Alkis

PY - 2012/3

Y1 - 2012/3

N2 - Asthma clinical research will highly benefit from standardization of major outcomes in terms of definition and assessment methodology. This will permit useful comparisons across interventional or observational studies and will allow more effective data sharing. National Institutes of Health (NIH) institutes and the Agency for Healthcare Research and Quality convened a workshop involving 7 expert subcommittees to propose which asthma outcomes should be assessed with standardized methodology in future asthma clinical research studies. Each subcommittee utilized comprehensive literature reviews and expert opinion to compile a list of asthma outcomes and classified them as either core (required in future studies), supplemental (to be used according to study aims and standardized), or emerging (requiring validation and standardization). This work was discussed at an NIH-organized workshop in March 2010 and finalized in September 2011. Outcomes for study participant characterization, as well as for prospective clinical trial intervention and observational studies, were proposed for adults and children, and methodologies for outcome collection and reporting were determined. Furthermore, the workshop identified areas in which new outcomes or instruments for their measurement need to be developed and validated. Standardized outcomes for clinical research in asthma have been proposed. Participating NIH institutes and other federal agencies will consider these recommendations in future clinical research initiatives in asthma. Published by Mosby, Inc.

AB - Asthma clinical research will highly benefit from standardization of major outcomes in terms of definition and assessment methodology. This will permit useful comparisons across interventional or observational studies and will allow more effective data sharing. National Institutes of Health (NIH) institutes and the Agency for Healthcare Research and Quality convened a workshop involving 7 expert subcommittees to propose which asthma outcomes should be assessed with standardized methodology in future asthma clinical research studies. Each subcommittee utilized comprehensive literature reviews and expert opinion to compile a list of asthma outcomes and classified them as either core (required in future studies), supplemental (to be used according to study aims and standardized), or emerging (requiring validation and standardization). This work was discussed at an NIH-organized workshop in March 2010 and finalized in September 2011. Outcomes for study participant characterization, as well as for prospective clinical trial intervention and observational studies, were proposed for adults and children, and methodologies for outcome collection and reporting were determined. Furthermore, the workshop identified areas in which new outcomes or instruments for their measurement need to be developed and validated. Standardized outcomes for clinical research in asthma have been proposed. Participating NIH institutes and other federal agencies will consider these recommendations in future clinical research initiatives in asthma. Published by Mosby, Inc.

UR - http://www.scopus.com/inward/record.url?scp=84860267851&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84860267851&partnerID=8YFLogxK

M3 - Article

C2 - 22386504

AN - SCOPUS:84860267851

VL - 129

JO - Journal of Allergy and Clinical Immunology

JF - Journal of Allergy and Clinical Immunology

SN - 0091-6749

IS - 3 Suppl

ER -